• Latest Posts
In Depth 15 Oct 2019

Four New Technologies That Will Change Cancer Treatment

European Biotech: The Insider View

CRISPR Therapeutics and Vertex Seal Deal Worth up to €890M

In Depth 11 Feb 2019

CRISPR: One Patent to Rule Them All

Abingworth Closes €268M to Invest in Life Science Companies


FDA Puts Clinical Trial for CRISPR Therapy on Hold

In Depth 13 Mar 2018

The Most Important Battle in Gene Editing: CRISPR versus TALEN

CRISPR Therapeutics Plans First CRISPR/Cas9 Clinical Trial in Europe for 2018

In Depth 28 Nov 2017

Reviewing Gene Therapy: How Close is Biotech to Genetic Cures?